Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry
Objective To examine patterns of tumour necrosis factor inhibitor (TNFi) use in TNFi-naive and TNFi-experienced patients with psoriatic arthritis (PsA) in the USA.Methods All patients aged ≥18 years with PsA enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry who initiated a TNFi...
Saved in:
| Main Authors: | Philip J Mease, Jeffrey D Greenberg, Chitra Karki, Mei Liu, YouFu Li, Bernice Gershenson, Hua Feng, Peter Hur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-06-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/5/1/e000880.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study
by: Nathan den Broeder, et al.
Published: (2025-06-01) -
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance
by: Bogdan Batko, et al.
Published: (2024-07-01) -
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?
by: Annette H M van der Helm-van Mil, et al.
Published: (2024-09-01) -
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry
by: Philip J Mease, et al.
Published: (2019-06-01) -
Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance”
by: Manjeet Kumar Goyal
Published: (2025-01-01)